Literature DB >> 22034048

Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.

Aly Youssef1, Francesca Righetti, Danila Morano, Nicola Rizzo, Antonio Farina.   

Abstract

OBJECTIVE: To determine the performance of screening for late pre-eclampsia (PE) by maternal characteristics, uterine artery Doppler and a set of biochemical markers at 11 + 0 to 13 + 6 weeks' gestation.
METHODS: Prospectively enrolled women at 11 + 0 to 13 + 6 weeks. Maternal characteristics, highest UtA pulsatility index and serum placental biomarkers including pregnancy-associated plasma protein-A, placental growth factor, soluble fms-like tyrosine kinase 1, P-selectin and neutrophil gelatinase-associated lipocalin were recorded.
RESULTS: The rate of PE was 2.5% (13/528). Four (0.8%) had severe PE. A combined screening model that included placental growth factor, soluble fms-like tyrosine kinase 1 and neutrophil gelatinase-associated lipocalin could detect 77% of PE at a 10% false-positive rate. Mean risk for mild PE was 8.8% ± 6.4, mean risk for severe PE was 38.6% ± 4.3. Mean risk for controls was 2% ± 4.1.
CONCLUSION: This combination of maternal biochemical variables in the first trimester can detect a consistent number of late PE. Further studies on a new and independent series of data could confirm the presented results.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034048     DOI: 10.1002/pd.2848

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.

Authors:  Sun Min Kim; Joong Shin Park; Errol R Norwitz; Hee Jung Jung; Byoung Jae Kim; Chan-Wook Park; Jong Kwan Jun
Journal:  Reprod Sci       Date:  2013-02-25       Impact factor: 3.060

2.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

3.  Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population.

Authors:  Necmiye Dover; Hacer C Gulerman; Sevki Celen; Serkan Kahyaoglu; Okan Yenicesu
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

4.  Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1-Induced Preeclampsia Phenotype in Mice.

Authors:  Shenghong Zhang; Cuili Zou; Qiaoqin Zhang
Journal:  G3 (Bethesda)       Date:  2018-10-03       Impact factor: 3.154

5.  First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.

Authors:  Aditi R Saxena; Ellen W Seely; Janet W Rich-Edwards; Louise E Wilkins-Haug; S Ananth Karumanchi; Thomas F McElrath
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-04       Impact factor: 3.007

6.  Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.

Authors:  Rolf Becker; Thomas Keller; Holger Kiesewetter; Heiner Fangerau; Uta Bittner
Journal:  Arch Gynecol Obstet       Date:  2013-02-07       Impact factor: 2.344

Review 7.  Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis.

Authors:  Pensée Wu; Caroline van den Berg; Zarko Alfirevic; Shaughn O'Brien; Maria Röthlisberger; Philip Newton Baker; Louise C Kenny; Karolina Kublickiene; Johannes J Duvekot
Journal:  Int J Mol Sci       Date:  2015-09-23       Impact factor: 5.923

8.  Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use.

Authors:  Max Mönckeberg; Valentina Arias; Rosario Fuenzalida; Santiago Álvarez; Victoria Toro; Andrés Calvo; Juan P Kusanovic; Lara J Monteiro; Manuel Schepeler; Jyh K Nien; Jaime Martinez; Sebastián E Illanes
Journal:  Diagnostics (Basel)       Date:  2020-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.